While there has been some suggestion that NF1 loss of function mutations are associated with greater HER2 expression in breast cancers, it is unclear whether the differing NF1 copy number in this tumor contributed to the difference in HER2 expression10. Here, ERBB2 is linked to breast carcinoma.